Imatinib mesylate therapy reduces bone marrow fibrosis in patients with chronic myelogenous leukemia

Carlos E. Bueso-Ramos, Jorge Cortes, Moshe Talpaz, Susan O'Brien, Francis Giles, Mary Beth Rios, L. Jeffrey Medeiros, Hagop Kantarjian

Research output: Contribution to journalArticlepeer-review

50 Scopus citations

Fingerprint

Dive into the research topics of 'Imatinib mesylate therapy reduces bone marrow fibrosis in patients with chronic myelogenous leukemia'. Together they form a unique fingerprint.

Medicine & Life Sciences